Alembic Pharmaceuticals announces USFDA approval for Desonide Lotion
Alembic Pharmaceuticals announces USFDA approval for Desonide Lotion

Alembic Pharmaceuticals announces USFDA approval for Desonide Lotion

Amir Shaikh Article rating: 5.0

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), DesOwen Lotion, 0.05 per cent of Galderma Laboratories LP. Desonide Lotion is low to medium potency corticosteroids indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 3.8

The market opened in green on August 25, 2020, overall volumes in futures & options currently stand at 1,92,04,237 crore contracts with a turnover of Rs. 13,31,390.82 crore.

Five-stocks-with-selling-interest
Five-stocks-with-selling-interest

Five-stocks-with-selling-interest

DSIJ Intelligence Article rating: 4.1

The market opened in green on August 24, 2020, overall volumes in futures & options currently stand at 1,25,46,616 crore contracts with a turnover of Rs. 8,85,496.25 crore.

Pharma companies unlikely to sustain healthy operating performance in Q1: Ind-Ra
Pharma companies unlikely to sustain healthy operating performance in Q1: Ind-Ra

Pharma companies unlikely to sustain healthy operating performance in Q1: Ind-Ra

Nidhi Jani Article rating: 4.8

It pointed out that pharma companies cumulatively witnessed their pre-tax margins rise by 306 bps on an annualised basis and 551 bps sequentially in Q1 due to the strong revenue growth in the active pharmaceutical ingredient (API) business and lower operating expenses.

Lupin gets USFDA approval for Albuterol Sulfate Inhalation Aerosol
Lupin gets USFDA approval for Albuterol Sulfate Inhalation Aerosol

Lupin gets USFDA approval for Albuterol Sulfate Inhalation Aerosol

Apurva Joshi Article rating: 3.8

Lupin Limited has informed the bourses that it has received United States Food and Drug Administration (USFDA) approval for its Albuterol Sulfate Inhalation Aerosol, 90 mcg (base)/actuation. It is a generic version of ProAir HFA.

RSS
First28002801280228032805280728082809Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR